Literature DB >> 1517354

Clinical review 37: Endocrine treatment of prostate cancer.

R J Santen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1517354     DOI: 10.1210/jcem.75.3.1517354

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  12 in total

1.  Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1alpha,25-dihydroxyvitamin D(3) in prostate cancer cells.

Authors:  Yong Xu; Fang Fang; Daret K St Clair; Sajni Josson; Pradoldej Sompol; Ivan Spasojevic; William H St Clair
Journal:  Mol Cancer Ther       Date:  2007-06-29       Impact factor: 6.261

2.  Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer.

Authors:  A Rodriguez-Gonzalez; K Cyrus; M Salcius; K Kim; C M Crews; R J Deshaies; K M Sakamoto
Journal:  Oncogene       Date:  2008-09-15       Impact factor: 9.867

Review 3.  Screening for prostate cancer. Implications for drug therapy.

Authors:  R H Harwood
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

4.  Prx1 enhances androgen receptor function in prostate cancer cells by increasing receptor affinity to dihydrotestosterone.

Authors:  Rishi Raj Chhipa; Kwang-Soon Lee; Sergio Onate; Yue Wu; Clement Ip
Journal:  Mol Cancer Res       Date:  2009-09-08       Impact factor: 5.852

5.  ARA67/PAT1 functions as a repressor to suppress androgen receptor transactivation.

Authors:  Yanqing Zhang; Yue Yang; Shuyuan Yeh; Chawnshang Chang
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

Review 6.  Gonadotrophin-releasing hormone agonists. A guide to use and selection.

Authors:  M Filicori
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

7.  Gonadotropin-releasing hormone (GnRH)-I and GnRH-II induce cell growth inhibition in human endometrial cancer cells: involvement of integrin beta3 and focal adhesion kinase.

Authors:  Dong Wook Park; Kyung-Chul Choi; Colin D MacCalman; Peter C K Leung
Journal:  Reprod Biol Endocrinol       Date:  2009-08-05       Impact factor: 5.211

Review 8.  Endometriosis and pain in the adolescent- striking early to limit suffering: A narrative review.

Authors:  Christine B Sieberg; Claire E Lunde; David Borsook
Journal:  Neurosci Biobehav Rev       Date:  2019-12-17       Impact factor: 8.989

9.  Rosemary (Rosmarinus officinalis) extract modulates CHOP/GADD153 to promote androgen receptor degradation and decreases xenograft tumor growth.

Authors:  Sakina M Petiwala; Saba Berhe; Gongbo Li; Angela G Puthenveetil; Ozair Rahman; Larisa Nonn; Jeremy J Johnson
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

10.  Predictors of early androgen deprivation treatment failure in prostate cancer with bone metastases.

Authors:  Eberhard Varenhorst; Rami Klaff; Anders Berglund; Per Olov Hedlund; Gabriel Sandblom
Journal:  Cancer Med       Date:  2016-01-14       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.